Christina has over 30 years of experience in strategy, biopharmaceutical development and business operations.

She was most recently the Chief Operating Officer at Nido Biosciences, leading all General & Administrative functions as well as manufacturing. Prior to joining Nido Bio, Christina was Chief Strategy Officer at Flexion Therapeutics, leading corporate strategy and business prioritization, program/portfolio management and human resources. She spent over 12 years in executive leadership roles building Flexion from its early financing, through pipeline evolution, development and commercialization of Zilretta®, and acquisition of the company, with influence across all business areas. 

Prior to joining Flexion, Christina was Vice President, Product Development and a member of the Executive Management team at Viacell, Inc. with cross-functional responsibility for the company’s cellular therapy and fertility preservation development programs. She also previously served as Senior Director, Product Development at The Medicines Company (TMC), focused on cardiovascular therapy clinical and product development (Angiomax®), and held ascendant clinical/product development roles at TMC, Astra Pharmaceuticals and Biopure Corporation. 

Christina holds a bachelor’s degree in biology with high distinction from Worcester Polytechnic Institute.